Remuneration

Fiscal year 2022-23

1. Total annual spending on remuneration paid to full-time permanent employees was $16,395,425 for the year ended December 31, 2022.

2. Total number of full-time permanent employees as of March 31, 2023, is 135.

3. Total compensation for the year ended December 31, 2022 (as reported on 2022 T4) for the following employees:

Title Remuneration (2022 T4 slips) Taxable benefits (included in remuneration figure)
Chief Executive Officer $658,996.12 $4,505.97
VP, Cancer Control $237,044.49 $3,749.13
VP, Finance & Corporate Services $295,292.20 $4,716.08
VP, Strategic Partnerships $284,460.79 $4,216.08
VP, Cancer Systems, Performance, & Innovation $284,951.87 $4,707.16

4. Partnership staff salary ranges (in effect as of March 31, 2023):

Level Position Annual remuneration range Number of full-time permanent
employees
9 Director $139,542 – $192,075 14
8 Regional Lead $116,285- $160,063 1
7 Manager, Sr. HR Business Partner, Program Manager, Controller, Lead, Enterprise Architect $96,904 – $133,386 34
6 Analyst, Program Manager, Service Manager, Lead, Specialists, Advisor, Senior Accountant, Web Developer, Project Manager $77,523 – $104,885 49
5 Analysts, Officer $68,003 – $92,003 13
4b Senior Executive Assistant $59,326 – $80,705 2
4 Coordinator $52,326 – $70,794 12
3 Administrative Assistant $45,900 – $62,100 5
  TOTAL 135*

*Includes 130 employees + 5 executives

5. Total remuneration paid to Partnership Board members for the year ended December 31, 2022 (as reported to Revenue Canada on 2022 T4 slips) was $102,800.

Partnership remuneration